Adverum Biotechnologies Cash from Investing (TTM) Analysis

Adverum Biotechnologies Inc (ADVM)

10.37 -0.26 (-2.45%) USD | NASDAQ | May 07, 12:25

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	96.88M
September 30, 2023	108.99M
June 30, 2023	115.16M
March 31, 2023	78.87M
December 31, 2022	141.72M
September 30, 2022	163.37M
June 30, 2022	149.47M
March 31, 2022	156.51M
December 31, 2021	78.71M
September 30, 2021	66.40M
June 30, 2021	-76.44M
March 31, 2021	-202.84M
December 31, 2020	-280.17M
September 30, 2020	-310.95M
June 30, 2020	-193.60M
March 31, 2020	-141.56M
December 31, 2019	-68.07M
September 30, 2019	-40.84M
June 30, 2019	-4.682M
March 31, 2019	46.81M
December 31, 2018	69.44M

Date	Value
September 30, 2018	96.11M
June 30, 2018	77.60M
March 31, 2018	42.03M
December 31, 2017	-122.20M
September 30, 2017	-157.82M
June 30, 2017	-160.81M
March 31, 2017	-137.70M
December 31, 2016	38.78M
September 30, 2016	69.76M
June 30, 2016	79.45M
March 31, 2016	84.83M
December 31, 2015	-41.57M
September 30, 2015	-72.00M
June 30, 2015	-81.42M
March 31, 2015	-89.68M
December 31, 2014	-0.943M
September 30, 2014	-0.588M
June 30, 2014	-0.484M
March 31, 2014	-0.06M
December 31, 2013	-0.091M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-310.95M

Minimum

Sep 2020

163.37M

Maximum

Sep 2022

-8.583M

Average

66.40M

Median

Sep 2021

Cash from Investing (TTM) Benchmarks